SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001140361-23-016754
Filing Date
2023-04-05
Accepted
2023-04-05 17:05:03
Documents
5
Effectiveness Date
2023-04-05

Document Format Files

Seq Description Document Type Size
1 S-8 brhc10050772_s8.htm S-8 56864
2 EXHIBIT 5.1 brhc10050772_ex5-1.htm EX-5.1 11750
3 EXHIBIT 23.1 brhc10050772_ex23-1.htm EX-23.1 1864
4 EXHIBIT 107 brhc10050772_ex107.htm EX-FILING FEES 33336
5 image00001.jpg GRAPHIC 69112
  Complete submission text file 0001140361-23-016754.txt   200306
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Ocuphire Pharma, Inc. (Filer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-271150 | Film No.: 23803392
SIC: 2834 Pharmaceutical Preparations